A Few Things that USPTO Could Do to Simplify Patent Prosecution

By Michael Borella — The US Patent and Trademark Office handles hundreds of thousands of patent applications per year, as well as various types of administrative patent proceedings. While the USPTO has made incremental improvements in its examination practices and IT systems to streamline applicant workflows, there are a number of relatively small changes that … Read more

House Committee Targets AbbVie Patent Practices, Urges FTC to Investigate

“It took 155 years for the USPTO to issue its first 5 million patents in 1991; it has taken less than 1/5 of that time to issue the next 6 million. Have we really become more inventive in the last 30 years or have we just got better at inventing patents?” Tamir Amin, Initiative for … Read more

A Guide for Foreign Chinese Patent Holders

“Speed ​​will be of the essence if China’s patent linkage system is to be useful to US patent holders.” In compliance with the Phase One Trade Agreement, China has implemented a patent linkage system in their amended patent law, which became effective June 1, 2021 (Article 76 of the Patent Law of the People’s Republic … Read more

Federal Court rejects motion for summary judgment in Canadian patent infringement case following voluntary dismissal of parallel US litigation

In a recently released decision, the Federal Court (FC) considered what happens when a patent infringement plaintiff agrees to resolve a dispute in a foreign jurisdiction, but continues to press parallel litigation against the same defendant in Canada. In this case, the defendant sought summary judgment based on the terms of a voluntary dismissal between … Read more

I-MAK Defends Integrity of Its Patent Data in Response to Tillis Letter

“At the time of writing in 2018, 11 out of the 12 drugs did not have any generic or biosimilar competition in the United States. Even the drug that did have competition (Remicade) at the time of writing was limited to only one competitor.” I-MAK letter The Initiative for Medicines, Access & Knowledge (I-MAK) has … Read more